Joanna Siegall | Senior Manager of Corporate Communications and IR |
Robert Blum | President and CEO |
Fady Malik | EVP of R&D |
Stuart Kupfer | SVP and Chief Medical Officer |
Robert Wong | VP and CAO |
Ching Jaw | SVP and CFO |
Andrew Callos | CCO |
Dane Leone | Raymond James |
Joe Pantginis | H.C. Wainwright |
Yasmeen Rahimi | Piper Sandler |
Jeff Hung | Morgan Stanley |
Akash Tewari | Jefferies |
Salim Syed | Mizuho |
Jason Butler | JMP Securities |
Charles Duncan | Cantor Fitzgerald |
Rohit Bhasin | Needham and Company |
Good afternoon and welcome ladies and gentlemen to Cytokinetics Third Quarter 2021 Conference Call. At this time, I would like to inform you that this call is being recorded and that all participants are in a listen-only mode. At the company's request we will open the call for questions-and-answers after the presentation, we will allow for up to two questions per participant. I will now turn the call over to Joanna Siegall, Cytokinetics' Senior Manager of Corporate Communications and Investor Relations. Please go ahead.